Surgery for Cancers of the food pipe, stomach, bowel, pancreas, liver and bile ducts, done through keyhole and robotic surgery wherever it is safe.
Gastrointestinal Cancer, Cancer of the stomach, oesophagus, colon, rectum, liver, pancreas, and the biliary system, accounts for a significant proportion of all new Cancer diagnoses in India every year. These are Cancers that arise in organs that are central to daily life: eating, digestion, metabolism. When surgery is needed to treat them, the technical demands on the surgeon are among the highest in all of Oncology.
The gastrointestinal (GI) tract is the digestive system: the food pipe, stomach, small bowel, colon and rectum, along with the liver, pancreas, gallbladder and bile ducts. Cancer treatment in Bangalore for these organs can include surgery, chemotherapy, radiation therapy and targeted treatment. For most GI Cancers found before they spread, surgery is the main treatment option, and the aim is to remove the whole tumour while protecting quality of life.
Dr Dinesh Mavinahalli Gangaiah, MS, MCh (Surgical Oncology), is a GI and Thoracic Minimally Invasive and Robotic Surgical Oncologist at ARC Cancer Hospital, Bengaluru. His practice in gastrointestinal Oncology surgery covers the full spectrum of GI Cancers, from the oesophagus to the rectum, from the liver to the pancreas, delivered predominantly through minimally invasive and robotic platforms that offer patients smaller incisions, less pain, shorter hospital stays, and faster return to normal life, without compromising the Oncological rigour that determines long-term outcomes.
GI Cancer surgery is among the most technically demanding surgical disciplines. The organs involved: the oesophagus traversing the chest and abdomen, the stomach with its complex vascular supply, the pancreas with its proximity to major vessels, the liver with its segmental anatomy, the rectum with its relationship to the pelvic floor and sphincter complex, each require a different set of technical skills, anatomical knowledge, and Oncological understanding.
Dr Dinesh Mavinahalli Gangaiah performs the following GI Cancer surgeries at ARC Cancer Hospital, Bengaluru, predominantly through minimally invasive (laparoscopic) and robotic platforms:
| Cancer Type | Minimally Invasive / Robotic Procedure | Why this approach |
|---|---|---|
| Oesophageal Cancer (Cancer of the Food Pipe) | Minimally Invasive Oesophagectomy (MIO): combined thoracoscopic (chest) and laparoscopic (abdominal) approach; robotic-assisted oesophagectomy | Oesophageal Cancer surgery crosses the chest and abdomen, a very demanding procedure; minimally invasive oesophagectomy reduces pulmonary complications, hospital stay, and recovery time compared to open surgery; robotic assistance provides better visualisation and precision in the narrow thoracic field |
| Stomach Cancer (Gastric Cancer) | Laparoscopic or robotic total gastrectomy; laparoscopic or robotic distal gastrectomy (subtotal); D2 lymph node dissection, the international standard for gastric Cancer | Robotic D2 lymph node dissection achieves better nodal yield compared to conventional laparoscopy in the perigastric and coeliac axis nodal stations; precise vascular control; meticulous anastomotic construction; significantly reduced blood loss and shorter hospital stay vs open gastrectomy |
| Colorectal Cancer (Colon and Rectal Cancer) | Laparoscopic or robotic right hemicolectomy; left hemicolectomy; sigmoid colectomy; anterior resection (rectal Cancer); low anterior resection; abdominoperineal resection (APR); total mesorectal excision (TME) | Robotic TME for rectal Cancer, the most technically demanding colorectal procedure, achieves better mesorectal plane quality in the narrow male pelvis compared to laparoscopy; nerve-sparing TME preserves urinary and sexual function; robotic precision is particularly advantageous for low rectal tumours in obese male patients |
| Pancreatic Cancer (Pancreatic and Periampullary) | Laparoscopic or robotic pancreaticoduodenectomy (Whipple procedure); distal pancreatectomy with splenectomy; central pancreatectomy for selected lesions | Minimally invasive Whipple surgery, one of the most complex GI operations, reduces blood transfusion requirement and hospital stay when performed by experienced surgeons; robotic platform provides enhanced dexterity for the pancreaticojejunostomy and hepaticojejunostomy anastomoses, the most technically demanding reconstruction steps |
| Liver Cancer (Primary and Secondary) | Laparoscopic or robotic liver resection: segmentectomy, hemihepatectomy, non-anatomical resection; anatomical liver resection guided by intraoperative ultrasound | Laparoscopic liver resection significantly reduces blood loss, hospital stay, and post-operative pain compared to open hepatectomy; the pneumoperitoneum pressure reduces venous bleeding from the liver surface; robotic assistance improves precision for resections in difficult anatomical locations (posterior right lobe, segment 7/8) |
| Gallbladder Cancer | Radical cholecystectomy: en-bloc resection of gallbladder with liver bed (segments 4b and 5) and regional lymph node dissection; laparoscopic or open depending on stage and prior cholecystectomy history | Gallbladder Cancer is the most common biliary malignancy in India; in patients where Cancer is found incidentally after laparoscopic cholecystectomy, re-operation with radical cholecystectomy is required; surgical approach is determined at the Multidisciplinary Tumour Board based on stage and prior procedure |
| Biliary Cancer (Cholangiocarcinoma) | Resection of perihilar, intrahepatic, or distal cholangiocarcinoma; hepaticojejunostomy biliary reconstruction; combined liver resection and biliary reconstruction where required | Cholangiocarcinoma, Cancer of the bile ducts, requires complex hepatobiliary surgery with biliary reconstruction; the technical demands are among the highest in GI Oncology; staging and resectability are assessed at the Multidisciplinary Tumour Board before surgical planning |
| GIST (Gastrointestinal Stromal Tumour) | Laparoscopic or robotic wedge resection of the stomach or small bowel; segmental resection for intestinal GIST | GIST is treated primarily with surgical resection for localised disease; laparoscopic wedge resection of gastric GIST avoids formal gastrectomy and preserves maximum gastric volume; margins are confirmed intraoperatively; systemic therapy coordination for high-risk GIST post-resection |
| Small Bowel and Intestinal Cancers | Segmental small bowel resection; ileocaecal resection; laparoscopic approach for accessible lesions | Small bowel Cancers are rare; surgical resection with adequate margins and lymph node dissection is the primary treatment; laparoscopic approach achieves equivalent Oncological outcomes with reduced recovery time for most small bowel locations |
Every patient considering GI Cancer surgery deserves an honest comparison between open surgery, the traditional approach, and minimally invasive or robotic surgery, the approach Dr Dinesh Mavinahalli Gangaiah applies for the majority of eligible patients. The evidence from multiple large randomised controlled trials and systematic reviews is consistent:
| Open Surgery | Minimally Invasive / Robotic | |
|---|---|---|
| Hospital Stay | 7 to 14 days | 3 to 6 days |
| Blood Loss | Higher; transfusion more likely | Significantly reduced; transfusion rarely needed |
| Post-op Pain | Significant; opioid requirement higher | Substantially less; earlier mobilisation |
| Return to Normal Activity | 6 to 8 weeks | 2 to 4 weeks |
| Wound Complications | Higher infection and hernia rates | Smaller incisions; significantly lower wound complication rates |
| Oncological Outcomes | Equivalent for experienced surgeons | Equivalent: same margin clearance, same nodal yield, same long-term survival |
| Visualisation | Direct, unaided | Robotic: 10 to 15× magnified 3D; laparoscopic: HD camera, clearer than the naked eye |
| Suitability | All patients | Most patients; some advanced local disease may require open approach, discussed at Tumour Board |
The Oncological outcomes, Cancer clearance, lymph node harvest, long-term survival, are equivalent between minimally invasive and open GI surgery in the hands of an experienced surgeon. The patient experience benefits of minimally invasive surgery are not a compromise. They are additional advantages achieved without sacrificing the Oncological standard.
Robotic surgery in GI Oncology represents the current frontier of minimally invasive Cancer surgery, and it offers specific advantages over conventional laparoscopy in GI procedures that are technically demanding, anatomically constrained, or require precise reconstruction.
No GI Cancer surgery at ARC Cancer Hospital is planned by a single surgeon in isolation. Every patient’s case is reviewed at the Multidisciplinary Tumour Board, bringing together surgical Oncology, medical Oncology, radiation Oncology, pathology, and radiology, before the surgical plan is confirmed.
Your first consultation with Dr Dinesh Mavinahalli Gangaiah is a comprehensive clinical assessment, a review of all available imaging, pathology reports, and clinical history, followed by an examination and a detailed discussion of the diagnosis, surgical options, and the overall treatment plan. You are encouraged to bring a family member or a trusted person who can support you in processing the information discussed.
At the end of the first consultation, you will leave with a clear understanding of: your diagnosis and stage; whether surgery is recommended and at what point in the treatment sequence; which surgical approach is planned (minimally invasive, robotic, or open) and why; what the surgery involves and what recovery looks like; what the alternatives to surgery are.
Dr Dinesh Mavinahalli Gangaiah practises at ARC Cancer Hospital, Bengaluru, located at Dr MH Marigowda Road, Lakkasandra, Hombegowda Nagar, Bengaluru, 560027. He sees patients from across Bengaluru and Karnataka, and from across South India.
GI Oncology surgery is a superspeciality that focuses specifically on surgical treatment of Cancers of the gastrointestinal tract, the oesophagus, stomach, small intestine, colon, rectum, appendix, liver, pancreas, gallbladder, and bile ducts. Dr Dinesh Mavinahalli Gangaiah holds an MCh in Surgical Oncology, a dedicated three-year superspeciality training in Cancer surgery beyond his MS in Surgery, which means his entire training has been focused on Oncological surgical principles, complex GI reconstruction, and minimally invasive techniques for Cancer. This is distinct from a general surgeon who performs Cancer operations alongside a broader surgical practice.
Multiple large randomised controlled trials, including the CLASICC trial for colorectal Cancer, the CLASS trial for gastric Cancer, and studies on laparoscopic Whipple surgery, have confirmed that minimally invasive GI Cancer surgery achieves equivalent Oncological outcomes to open surgery in terms of margin clearance, lymph node harvest, and long-term survival. The benefits of minimally invasive surgery, smaller incisions, less pain, shorter hospital stay, faster recovery, are genuine patient experience improvements that are achieved without any compromise to the Oncological standard. For most patients with GI Cancer, minimally invasive surgery is not a lesser option. It is the better option, both Oncologically and experientially.
Both laparoscopic and robotic surgery are minimally invasive, performed through small incisions rather than a large open cut. The difference is in the surgical instruments and visualisation. Laparoscopic surgery uses rigid instruments held directly by the surgeon, with a 2D or HD camera view. Robotic surgery uses a console at which the surgeon sits and controls flexible robotic arms with seven degrees of freedom, instruments that replicate the natural movement of the human wrist, with 10 to 15 times magnified 3D high-definition visualisation. For complex GI reconstructions (oesophageal, pancreatic), precise anatomical dissection (rectal Cancer TME), and difficult access locations (posterior liver, low pelvis), robotic surgery offers meaningful technical advantages over conventional laparoscopy.
Not every GI Cancer requires surgery, and the decision depends on the Cancer type, stage, location, and your overall health and fitness. For many localised GI Cancers, surgery is the primary curative treatment. For others, chemotherapy or chemoradiation before surgery (neoadjuvant therapy) is recommended to improve outcomes. For metastatic disease, surgery may still have a role in selected patients, or systemic therapy may be the primary approach. The decision is never made by Dr Dinesh alone, it is reviewed at the Multidisciplinary Tumour Board at ARC Cancer Hospital, where surgical, medical, and radiation Oncology specialists together determine the optimal treatment sequence for each patient. Your consultation with Dr Dinesh will give you a clear understanding of what is recommended for your specific situation and why.
A Whipple procedure (pancreaticoduodenectomy) is the surgical removal of the head of the pancreas, the duodenum (first part of the small bowel), the gallbladder, the bile duct, and sometimes part of the stomach, followed by complex reconstruction reconnecting the remaining pancreas, bile duct, and stomach to the small bowel. It is required for Cancers of the head of the pancreas, the bile duct at its lower end, the ampulla of Vater, and the duodenum, collectively called periampullary Cancers. The Whipple is one of the most technically demanding operations in GI surgery, requiring specialised surgical expertise. Dr Dinesh Mavinahalli Gangaiah performs minimally invasive (laparoscopic and robotic) Whipple surgery at ARC Cancer Hospital, achieving equivalent Oncological outcomes with reduced blood loss and shorter hospital stay compared to open surgery.
Recovery after GI Cancer surgery depends on the specific procedure and the surgical approach. For minimally invasive and robotic GI Cancer surgery: most patients are mobilised the day after surgery, eating soft food within 2 to 5 days, discharged from hospital in 3 to 7 days, and returning to light activities within 2 to 4 weeks. Complete recovery to full normal activity typically takes 4 to 8 weeks depending on the extent of the procedure. These timelines are significantly shorter than after equivalent open surgery, which typically requires 7 to 14 days in hospital and 8 to 12 weeks to full recovery. Dr Dinesh follows Enhanced Recovery After Surgery (ERAS) protocols at ARC Cancer Hospital, structured peri-operative care pathways that have been shown to reduce complications and accelerate recovery.
Yes. GI Cancer surgery, including oesophagectomy, gastrectomy, colectomy, anterior resection, Whipple procedure, liver resection, and other GI Oncological procedures, is covered under most major health insurance providers and under Ayushman Bharat / PMJAY for eligible patients at ARC Cancer Hospital. Our patient services team at ARC Cancer Hospital provides pre-authorisation support for insurance claims. Please contact us at +91 99160 99360 or use the appointment booking system to discuss your specific insurance coverage before scheduling surgery.
A CT scan can show a thickened stomach wall or signs that a Cancer has spread, so it is used to stage stomach Cancer. It cannot confirm the diagnosis on its own. That needs an endoscopy, where a thin camera looks inside the stomach, and a biopsy of any abnormal area.
Some can. Colonoscopy can find colon Cancer early, and often finds polyps before they turn into Cancer. Ongoing blood in the stool, a change in bowel habits, difficulty swallowing, weight loss without trying or indigestion that does not settle should be checked by a doctor without delay.
This website gives general information about Cancer and Cancer surgery. It is not medical advice for your situation and does not replace a consultation with a qualified doctor.
Copyright© 2026 Dr Dinesh Mavinahalli Gangaiah. Privacy Policy · Terms & Conditions
